Meng Ma

Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy

Yan Kong, Xinan Sheng, Xiaowen Wu et al. · Clinical Cancer Research · 2017 · 116 citations

Medicine, Molecular Genetics, Oncology +17

Analysis of <i>mTOR</i> Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K–AKT–mTOR Pathway Inhibitors

Yan Kong, Lu Si, Yiqian Li et al. · Clinical Cancer Research · 2015 · 83 citations

Medicine, Molecular Genetics, Oncology +17

miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapy

Huan Tang, Meng Ma, Jie Dai et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 59 citations · Full text

Medicine, Cancer Biology, Oncology +17

Comparative analyses of population-scale phenomic data in electronic medical records reveal race-specific disease networks

Benjamin S. Glicksberg, Li Li, Marcus A. Badgeley et al. · Bioinformatics · 2016 · 48 citations · Full text

Medicine, Biomedical Informatics, Electronic Health Records +13

A composite biomarker of neutrophil-lymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers

Kristin L. Ayers, Meng Ma, Gaspard Debussche et al. · BMC Cancer · 2021 · 48 citations · Full text

Medicine, Immunology, Oncology +17